December 9, 2021 Fecal Transplant Discovery Could Improve Care for Dangerous Infections

New research sheds light on why a fecal transplant can benefit patients with recurrent C. difficile infections.

December 7, 2021 Link Found Between Lupus, Macular Degeneration

Lupus and macular degeneration, a leading cause of vision loss, share a common contributor to harmful inflammation, UVA researchers found.

December 6, 2021 UVA Health Joins National Effort to Improve Outcomes for Mothers and Babies

To support better health outcomes for mothers and newborns, UVA Health and UVA Children’s are joining the U.S. Department of Health and Human Services (HHS) Perinatal Improvement Collaborative.

December 3, 2021 iTHRIV Grants Target Obesity Among Latinx Youth, Hepatitis C

The integrated Translational Health Research Institute of Virginia has awarded almost $80,000 across two community-focused projects. 

December 2, 2021 Driving Simulator Goes Virtual to Help More People With Autism

Researcher Daniel J. Cox is testing a virtual-reality driving simulator to see if it can help people with autism and other novice drivers become safer behind the wheel.

November 22, 2021 UVA Develops Precise Brain Surgery Without a Scalpel

School of Medicine researchers have developed a noninvasive way to remove faulty brain circuits that could allow doctors to treat debilitating neurological diseases without the need for conventional brain surgery.

November 17, 2021 Children’s Hospital of Richmond at VCU, UVA Children’s Develop Regional Collaboration to Provide Heart Surgery for Children in Virginia

Children’s Hospital of Richmond at VCU and UVA Children’s are teaming up to ensure children and families in Virginia have convenient access to…

November 17, 2021 FDA Approves Focused Ultrasound for Parkinson’s Symptoms

The incisionless form of brain surgery was tested at the School of Medicine.

November 16, 2021 iTHRIV Backs Bids to Improve Lung Transplant Outcomes, Reduce Waste

The integrated Translational Health Research Institute of Virginia (iTHRIV) has awarded $200,000 in pilot funding across five multi-institutional research projects.

November 11, 2021 Drug Tested at UVA Offers Lasting COVID-19 Protection

The antibody cocktail reduced the risk of COVID-19 infection by more than 80% for more than eight months, Regeneron Pharmaceuticals announced.